Skip to main content
Navigate back to homepage
Open search bar.
Open main navigation menu

Main navigation

  • Study
    UCL Portico statue
    Study at UCL

    Being a student at UCL is about so much more than just acquiring knowledge. Studying here gives you the opportunity to realise your potential as an individual, and the skills and tools to thrive.

    • Undergraduate courses
    • Graduate courses
    • Short courses
    • Study abroad
    • Centre for Languages & International Education
  • Research
    Tree-of-Life-MehmetDavrandi-UCL-EastmanDentalInstitute-042_2017-18-800x500-withborder (1)
    Research at UCL

    Find out more about what makes UCL research world-leading, how to access UCL expertise, and teams in the Office of the Vice-Provost (Research, Innovation and Global Engagement).

    • Engage with us
    • Explore our Research
    • Initiatives and networks
    • Research news
  • Engage
    UCL Print room
    Engage with UCL

    Discover the many ways you can connect with UCL, and how we work with industry, government and not-for-profit organisations to tackle tough challenges.

    • Alumni
    • Business partnerships and collaboration
    • Global engagement
    • News and Media relations
    • Public Policy
    • Schools and priority groups
    • Visit us
  • About
    UCL welcome quad
    About UCL

    Founded in 1826 in the heart of London, UCL is London's leading multidisciplinary university, with more than 16,000 staff and 50,000 students from 150 different countries.

    • Who we are
    • Faculties
    • Governance
    • President and Provost
    • Strategy
  • Active parent page: Brain Sciences
    • Study
    • Research
    • About the Faculty
    • Institutes and Divisions
    • Active parent page: News and Events
    • Contact

Cerebral amyloid angiopathy (CAA) may be caused by prions

A study published in Annals of Neurology, by Dr Gargi Banerjee and colleagues, led by Professor David Werring, UCL Queen Square Institute of Neurology, adds to evidence that prion diseases are more widespread and varied than had been realised

15 February 2019

Breadcrumb trail

  • Brain Sciences
  • News and Events

Faculty menu

  • Current page: Faculty news
  • Events

Three people who were diagnosed with cerebral amyloid angiopathy (CAA), a brain disease related to Alzheimer’s disease, likely developed the disease due to the transmission of amyloid pathology during neurosurgery decades earlier, according to the study.  All three people had received cadaveric dura mater grafts – transplants of the tissue that covers the brain – when they were young, before developing CAA three to four decades later. The procedure was discontinued in the UK in 1992.

It’s the first case study of people who have received a CAA diagnosis during their lifetime attributed to neurosurgery, building on previous post-mortem evidence of possible amyloid transmission from dura mater grafts, contaminated neurosurgical instruments and growth hormone transplants.

CAA is a buildup of amyloid proteins that can cause strokes or brain bleeds, and typically occurs only in much older patients than the three people described in the study. CAA is often seen in people with Alzheimer’s disease, which is caused by the same buildup of proteins, but the patients in this study have not been diagnosed with Alzheimer’s. The three patients described in the study were in their 30s and 40s when they experienced symptoms including seizures, headaches and brain bleeds, and were diagnosed with CAA.

They were the only patients out of 663 referred to a specialist intracerebral haemorrhage service (the cases reviewed in the study) who had been diagnosed with CAA before age 50. All three patients had received dura mater grafts three to four decades earlier.

The researchers say that doctors need to be aware of the risk of amyloid transmission contributing to CAA. In patients over 55, CAA can occur sporadically, but would normally not be considered as a diagnosis in younger patients – but this study adds to evidence that, particularly with younger patients presenting with CAA-related symptoms, doctors should ask if they have had neurosurgery earlier in life.

While there is no cure for CAA, there are ways to reduce the associated risks of stroke and brain bleeds if doctors have the right diagnosis, as they can avoid blood thinners and closely monitor the patient’s blood pressure.

Further information:

  • Banerjee et al. (2019) Early onset cerebral amyloid angiopathy following childhood exposure to cadaveric dura.  Annals of Neurology 2019;85:284-90.
  • Professor Werring's academic profile
  • Dr Banerjee's academic profile
  • Economist article
  • Amyloid protein transmission through neurosurgery
  • Amyloid pathology transmission in lab mice and historic medical treatments

Image:

Brain Image Findings Banerjee et al. (2019)

UCL footer

Visit

  • Bloomsbury Theatre and Studio
  • Library, Museums and Collections
  • UCL Maps
  • UCL Shop
  • Contact UCL

Students

  • Accommodation
  • Current Students
  • Moodle
  • Students' Union

Staff

  • Inside UCL
  • Staff Intranet
  • Work at UCL
  • Human Resources

UCL social media menu

  • Link to Soundcloud
  • Link to Flickr
  • Link to TikTok
  • Link to Youtube
  • Link to Instagram
  • Link to Facebook
  • Link to Twitter

University College London, Gower Street, London, WC1E 6BT

Tel: +44 (0) 20 7679 2000

© 2025 UCL

Essential

  • Disclaimer
  • Freedom of Information
  • Accessibility
  • Cookies
  • Privacy
  • Slavery statement
  • Log in